Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Conegliano

7 clinical trials in Conegliano, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Conegliano at a glance
7
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Conegliano

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Prax-628
  • Sponsor:Praxis Precision Medicines Inc.
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:2'-O-(2-Methoxyethyl) Modified Antisense Oligonucleotide Targeting Ube3A Antisense Transcript Rna
  • Sponsor:Ionis Pharmaceuticals Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:VORMATRIGINE
  • Sponsor:Praxis Precision Medicines Inc.
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Sulodexide
  • Sponsor:Fondazione Arianna Anticoagulazione

Partial seizures

Not recruiting
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Prax-628
  • Sponsor:Praxis Precision Medicines Inc.
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Canagliflozin
  • Sponsor:Center For Outcomes Research And Clinical Epidemiology S.r.l.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Conegliano

What the registry says about research in the country

01 Diabetes Management

Innovative research focusing on SGLT2 inhibitors in elderly patients with Type 2 diabetes mellitus, aiming to optimize glycemic control while preventing hypoglycemic events.

  • Blood glucose management
  • Elderly patient care
  • Medication safety assessment

The study evaluates treatment effectiveness over a 24-month period, specifically targeting individualized HbA1c goals.

02 Cardiovascular Health

Clinical investigation of Sulodexide in the prevention of recurring venous thromboembolism, specifically designed for elderly patients aged 75 and above.

  • Thrombosis prevention
  • Geriatric medicine
  • Blood vessel health

The research focuses on both efficacy and safety, with particular attention to bleeding risk assessment.

03 Neurological Disorders

Advanced clinical research evaluating a novel therapeutic approach for patients with focal epilepsy, testing the effectiveness of PRAX-628 in combination with existing treatments.

  • Seizure management
  • Anticonvulsant therapy
  • Neurological treatment

This study aims to enhance seizure control in adults currently using multiple anti-seizure medications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.